End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.4 TWD | -2.06% | +6.32% | +13.48% |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 927.8 |
Enterprise Value (EV) 1 | 1,207 |
P/E ratio | 30 x |
Yield | 3.03% |
Capitalization / Revenue | 2.74 x |
EV / Revenue | 3.56 x |
EV / EBITDA | 10.2 x |
EV / FCF | 5,767,375 x |
FCF Yield | 0% |
Price to Book | 1.19 x |
Nbr of stocks (in thousands) | 28,073 |
Reference price 2 | 33.05 |
Announcement Date | 3/29/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales 1 | 196.4 | 337 | 339.2 |
EBITDA 1 | 50.86 | 102.8 | 118.7 |
EBIT 1 | 16.76 | 46.64 | 45.94 |
Operating Margin | 8.53% | 13.84% | 13.55% |
Earnings before Tax (EBT) 1 | 14.32 | 45.41 | 38.24 |
Net income 1 | 11.28 | 35.57 | 35.14 |
Net margin | 5.74% | 10.56% | 10.36% |
EPS 2 | 0.5400 | 1.540 | 1.100 |
Free Cash Flow | - | -5.33 | 209.2 |
FCF margin | - | -1.58% | 61.69% |
FCF Conversion (EBITDA) | - | - | 176.28% |
FCF Conversion (Net income) | - | - | 595.35% |
Dividend per Share | - | 1.000 | 1.000 |
Announcement Date | 4/25/22 | 4/25/22 | 3/29/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | 276 | 14.9 | 279 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | 5.419 x | 0.1449 x | 2.35 x |
Free Cash Flow | - | -5.33 | 209 |
ROE (net income / shareholders' equity) | - | 7.06% | 2.76% |
ROA (Net income/ Total Assets) | - | 3.1% | 1.81% |
Assets 1 | - | 1,149 | 1,946 |
Book Value Per Share 2 | 17.60 | 23.80 | 27.70 |
Cash Flow per Share 2 | 2.370 | 15.00 | 7.540 |
Capex 1 | 157 | 97.4 | 60.5 |
Capex / Sales | 79.69% | 28.91% | 17.85% |
Announcement Date | 4/25/22 | 4/25/22 | 3/29/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+13.48% | 66.46M | |
+10.90% | 42.7B | |
+9.69% | 13.72B | |
+11.58% | 5.54B | |
+18.99% | 5.47B | |
+6.32% | 4.2B | |
+17.71% | 2.3B | |
-9.41% | 2.19B | |
-2.83% | 1.58B | |
-9.03% | 1.38B |
- Stock Market
- Equities
- 7578 Stock
- Financials Revivegen Co., Ltd.